24
Participants
Start Date
July 29, 2021
Primary Completion Date
October 25, 2022
Study Completion Date
October 18, 2023
Pozelimab
Administered Sub-cutaneous (SC) per protocol
Cemdisiran
Administered SC per protocol
Chang Gung Memorial Hospital, Taoyuan
D l Pesti Centrumk rh z Orsz gos Hematol giai s Infektol giai Int zet, Budapest
Yonsei University College of Medicine, Severance Hospital, Seoul
Ewha Womans University Medical Centre, Seoul
National Taiwan University Hospital, Taipei
Hospital Sultanah Nur Zahirah, Kuala Terengganu
Pusan National University Hospital, Busan
Hospital Sibu, Sibu
Hospital Miri, Miri
Prince of Wales Hospital, Hong Kong
Samsung Medical Center, Seoul
Seoul National University Hospital, Seoul
St. James's University Hospital, Leeds
Regeneron Pharmaceuticals
INDUSTRY